pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,912 catalysts · 5,256 phase readout · 2,332 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 61 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,332
  • pdufa321
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06767306: Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma

Sponsor: Melanoma Institute Australia. Phase: PHASE2. Conditions: Melanoma Metastatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT06593106: Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial

Sponsor: Vanderbilt-Ingram Cancer Center. Phase: NA. Conditions: Stage I Lung Cancer, Stage II Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07460206: Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica. Phase: PHASE2. Conditions: ccRCC

full page →ctgov ↗
›RECRUITINGphase readoutNCT07464704: Infrasensor for Early Detection of a High-grade Obstructive NSTE-ACS

Sponsor: Remote Cardiac Enablement. Phase: . Conditions: High Grade Obstructive NSTE-ACS

full page →ctgov ↗
›COMPLETEDphase readoutNCT04222504: Community-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Pre-Exposure Prophylaxis, STI, Contraceptive Usage

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07089784: Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›RECRUITINGphase readoutNCT03683433: Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Chronic Myelomonocytic Leukemia, IDH2 Gene Mutation, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07093333: A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

Sponsor: Arialys Australia Pty Ltd. Phase: PHASE2. Conditions: Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease, Autoimmune Encephalitis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07462052: Talk Parenting Education Program II

Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.. Phase: NA. Conditions: Parenting Practices, Self Efficacy, Stress, Child Behavior, Emotional Adjustment, Sleep Problem, Parent-Child Relations

full page →ctgov ↗
›RECRUITINGphase readoutNCT07290738: Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders

Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Schizophrenia Spectrum Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05848258: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Rheumatoid Arthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07353658: Effect of Intermittent Enteral Feeding in Severe Stroke

Sponsor: Xijing Hospital. Phase: NA. Conditions: Severe Stroke, Enteral Nutrition

full page →ctgov ↗
›RECRUITINGphase readoutNCT05473858: Oraverse Versus Laser

Sponsor: sara nabil. Phase: PHASE3. Conditions: Reversal of Local Anesthesia in Children

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06862648: Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence

Sponsor: Acoustic Wave Cell Therapy, Inc.. Phase: NA. Conditions: Stress Urinary Incontinence (SUI)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07316426: Preoptimisation in Ventral Hernia Surgery

Sponsor: Umeå University. Phase: NA. Conditions: Hernia, Hernia, Ventral, Hernia Incisional, Hernia, Umbilical

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07091643: Neuroimaging Markers of Midlife Depression and Cognitive Behavioural Therapy (CBT)

Sponsor: Baycrest. Phase: NA. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05419115: Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure

Sponsor: NHS Greater Glasgow and Clyde. Phase: PHASE2. Conditions: Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07552415: Does Joint Immobilization Following Revision Total Knee Arthroplasty Improve Range of Motion Following Surgery?

Sponsor: Hospital for Special Surgery, New York. Phase: NA. Conditions: Aseptic Revision Knee Arthroplasty, Stiffness Following Revision Knee Arthroplasty

full page →ctgov ↗
›RECRUITINGphase readoutNCT06171035: Use of 3D Printing High-fidelity Craniofacial Manikin to Teach Noninvasive Positive Pressure Ventilation

Sponsor: Fu Jen Catholic University. Phase: NA. Conditions: Satisfaction, Personal

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04749667: Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Sponsor: Haukeland University Hospital. Phase: PHASE1. Conditions: Multiple Sclerosis, Progressive Multiple Sclerosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07485465: Lymphoedema Diagnosis and Treatment

Sponsor: Fatih Sultan Mehmet Training and Research Hospital. Phase: . Conditions: Lymphedema, Artificial Intelligence (AI)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06309992: A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Sponsor: Boehringer Ingelheim. Phase: PHASE3. Conditions: Obesity, Non-Alcoholic SteatoHepatitis (NASH)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07006792: A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

Sponsor: Eli Lilly and Company. Phase: PHASE4. Conditions: Atopic Dermatitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07261436: Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Artificial Intelegence

full page →ctgov ↗
›COMPLETEDphase readoutNCT03037411: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries

Sponsor: Boston Scientific Corporation. Phase: . Conditions: Arterial Occlusive Diseases, Atherosclerosis, Vascular Diseases, Arteriosclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07507734: Occlusal Splint and Exercise Therapy for Temporomandibular Disorders

Sponsor: Acibadem University. Phase: NA. Conditions: Temporomandibular Disorders (TMD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07177209: Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

Sponsor: Pfizer. Phase: . Conditions: Ulcerative Colitis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07540299: Dipotassium Oxalate for Postoperative Sensitivity in NCCLs

Sponsor: Postgraduate Medical Institute, Lahore. Phase: NA. Conditions: Dentin Hypersensitivity, Post Operative Sensitivity Control

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07228299: Supporting Families in the ICU

Sponsor: Indiana University. Phase: NA. Conditions: Anxiety, Well-Being, Satisfaction

full page →ctgov ↗
›RECRUITINGphase readoutNCT05430698: PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE2. Conditions: Perihilar Cholangiocarcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07298798: To Compare the Effect of Closed Kinetic Chain and Isometric Exercises in Reducing Pain and Improving Functional Disability in Patients With Patellofemoral Pain Syndrome Associated With Knee Osteoarthritis

Sponsor: Dow University of Health Sciences. Phase: NA. Conditions: Knee Osteoarthritis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05820932: Predicting Cognitive Decline From Androgen Deprivation Therapy

Sponsor: University of California, San Francisco. Phase: . Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07538232: Oral Microecology in Children With Autism

Sponsor: The Dental Hospital of Zhejiang University School of Medicine. Phase: . Conditions: Autism, Caries,Dental

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07553221: Talar Osteochondral Lesions With Pilon Fractures

Sponsor: University of Missouri-Columbia. Phase: NA. Conditions: Pilon Fractures

full page →ctgov ↗
›RECRUITINGphase readoutNCT07506421: Hope Groups: Parenting and Mental Health Among Refugees in the Middle East

Sponsor: University of Oxford. Phase: NA. Conditions: Mental Health, Violence Against Children

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07473414: Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Osteoarthritis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07371416: Regenerative Root Canal Treatment of Immature Teeth Using Omega-3 Fatty Acids

Sponsor: Mansoura University. Phase: NA. Conditions: Immature Permanent Teeth With Open Apex, Pulp Necrosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07469306: Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Sponsor: Fujian Cancer Hospital. Phase: PHASE2. Conditions: Locally Advanced Rectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07100106: A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Sponsor: Genentech, Inc.. Phase: PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06736704: SNV4818 in Participants With Advanced Solid Tumors

Sponsor: Pikavation Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT07384806: Functional Training in Adolescent Table Tennis

Sponsor: Alirıza Han Civan. Phase: NA. Conditions: Functional Training in Adolescent Table Tennis Players

full page →ctgov ↗
›RECRUITINGphase readoutNCT07536204: Characterization of JAK1 and JAK2 Activation in Gingival Tissues During Homeostasis and Periodontitis

Sponsor: University of Chile. Phase: . Conditions: Periodontitis, Periodontal Diseases, Periodontal Inflammation, Gingival Diseases, Periodontal Attachment Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT00373347: Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

Sponsor: Stanford University. Phase: . Conditions: Liver Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07331649: Comparative Effects of Modified Tabata Training and Fartlek Training in Amateur Football

Sponsor: Riphah International University. Phase: NA. Conditions: Sports Physical Therapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT05934149: Lupus Landmark Study: A Prospective Registry and Biorepository

Sponsor: Lupus Research Alliance. Phase: . Conditions: Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07327138: Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.

Sponsor: Bahaa Bou Dargham. Phase: NA. Conditions: Acute Lymphoblastic Leukemia ALL

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05656248: Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Myeloid Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07286955: Life Skills Training for Soldiers Arriving at Their First Duty Location

Sponsor: Uniformed Services University of the Health Sciences. Phase: NA. Conditions: Risk Reduction Behavior, Suicide Prevention, Risky Behavior, Mental Health, Resilience, Performance at Work

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05905926: Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

Sponsor: Ardelyx. Phase: PHASE3. Conditions: Irritable Bowel Syndrome With Constipation (IBS-C)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04784585: Miro-randomized Trial for Optimizing a JITAI to Reduce Dietary Lapses in Obesity Treatment

Sponsor: The Miriam Hospital. Phase: NA. Conditions: Obesity

full page →ctgov ↗
← prev
page 59 of 159
next →